Tumor Tracking Systems Market
Tumor Tracking Systems Market Size, Share & Trends Analysis Report by Application (Prostate Cancer, Gastric Cancer, Lung Cancer, Breast Cancer, and Others), and by End User (Hospitals, Radiotherapy Centers, Cancer Research Institutes, and Others), Forecast Period (2023-2030) Update Available - Forecast 2024-2030
Tumor tracking systems market is anticipated to grow at a CAGR of 4.9% during the forecast period (2023–2030). The growth of the market is attributed to the growing development of digital pathology. Modern healthcare is incorporating more digital pathology technologies, such as sophisticated staining platforms such as Benchmark Ultra Plus. They enhance the overall diagnostic process by enabling remote cooperation, data storage, and analysis. For instance, in June 2022, Roche launched the BenchMark Ultra Plus system, its newest innovative tissue staining platform. Pathologists can deliver high-quality, time-sensitive results to doctors and patients owing to features that maximise workflow, test efficiency, and environmental sustainability.
Segmental Outlook
The global tumor tracking systems market is segmented by application and end-user. Based on the application, the market is sub-segmented into prostate cancer, gastric cancer, lung cancer, breast cancer, and others. Furthermore, based on the end-user, the market is sub-segmented into hospitals, radiotherapy centres, cancer research institutes, and others. Among the end-users, the cancer research institutes sub-segment is anticipated to hold a considerable share of the market owing to a rise in cancer awareness and research.
The Breast Cancer Sub-Segment is Anticipated to Hold a Considerable Share of the Global Tumor Tracking Systems Market
Among the applications, the breast cancer sub-segment is expected to hold a considerable share of the global tumour tracking systems market. The segmental growth is attributed to the growing use of advanced treatment technologies aimed at improving patient outcomes and quality of life. Similarly, the increasing prevalence of breast cancer and the focus on personalised and targeted therapies drive the demand for innovative solutions such as the Radixact System's capabilities for breast cancer treatment.
For instance, in August 2023, Accuray Incorporated launched the VitalHold breast package for the Radixact System. The package has already received a grant 510(k) approval by the US Food and Drug Administration (FDA). The Radixact System's fixed beam angle delivery mode (TomoDirect) and a fully integrated and automated surface-guided radiation therapy (SGRT) solution, utilizing the Catalyst+ HD system from C-RAD, and facilitating deep inspiration breath hold (DIBH) treatments with VitalHold. The Radixact System offers a complete toolkit for the treatment of breast cancer with the addition of these new capabilities. Subject to regulatory clearance or authorization, customers in the US, the European Union, and other locations are eligible to have an access of VitalHold technology.
Regional Outlook
The global tumor tracking systems market is further segmented based on geography, including North America (the US and Canada), Europe (the UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and the Rest of Asia), and the Rest of the World (the Middle East and Africa, and Latin America). Among these, Asia-Pacific is anticipated to hold a prominent share of the market across the globe. This market expansion is owing to the rising number of cases of cancer across the region. Additionally, the region lacks the awareness regarding cancer treatment due to low literacy rate and medical facilities compared to other regions.
Global Tumor Tracking Systems Market Growth by Region 2023-2030
The North America Region is Expected to Grow at a Significant CAGR in the Global Tumor Tracking Systems Market
Among all regions, the North American region is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to a rise in cancer cases. According to the American Cancer Society report published in January 2023, Prostate cancer is expected to be the most prevalent disease in American men, with an estimated 288,300 new cases of prostate cancer diagnosed in the country. It is also predicted that such a rise in cancer prevalence can boost the need for cancer treatment, ultimately driving the expansion of the industry in the region.
Additionally, in November 2022, Canadian Cancer Society estimated that over 233,900 people were diagnosed with cancer in 2022. In Canada, 21,100 men and 112,800 women were suffering with cancer. The most commonly diagnosed types of cancer in Canada are lung, breast, colorectal, and prostate cancer, which together account for 46% of all new cancer cases. Prostate cancer accounts for 20% of all new cancer cases in men, while lung cancer accounts for 13%. Apart from this, the breast cancer accounts for 25% of all new cancer cases in women, and colorectal cancer accounts for 10%.
US Cancer Rate by Type, 2022 (%)
Market Players Outlook
The major companies serving the Tumor Tracking Systems market include Cell Biolabs, Inc., HTG Molecular Diagnostics, Inc., Menarini Silicon Biosystems SpA, NanoString Technologies, Inc., NeoGenomics Laboratories, Inc., and others. The market players are considerably contributing to market growth through the adoption of various strategies, including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in October 2021, C-RAD AB partnered with Accuray Incorporated to boost the breast cancer treatment efficacy of the Accuray Radixact System. The C-RAD Catalyst+ HD and Radixact Systems can be used collaboratively by businesses to offer consumers a DIBH solution. The segment is anticipated to grow as a result of the activities completed.
The Report Covers
- Market value data analysis of 2022 and forecast to 2030.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global tumor tracking systems market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Key Company Analysis
3.2. Elekta
3.2.1. Overview
3.2.2. Financial Analysis
3.2.3. SWOT Analysis
3.2.4. Recent Developments
3.3. Exact Sciences Corp.
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
3.4. Genekam
3.4.1. Overview
3.4.2. Financial Analysis
3.4.3. SWOT Analysis
3.4.4. Recent Developments
3.5. Key Strategy Analysis
4. Market Segmentation
4.1. Global Tumor Tracking Systems Market by Application
4.1.1. Prostate Cancer
4.1.2. Gastric Cancer
4.1.3. Lung Cancer
4.1.4. Breast Cancer
4.1.5. Others (Pancreatic Cancer)
4.2. Global Tumor Tracking Systems Market by End User
4.2.1. Hospitals
4.2.2. Radiotherapy Centers
4.2.3. Cancer Research Institutes
4.2.4. Others (Ambulatory Surgical Centers)
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. Cell Biolabs, Inc.
6.2. HTG Molecular Diagnostics, Inc.
6.3. Menarini Silicon Biosystems SpA
6.4. NanoString Technologies, Inc.
6.5. NeoGenomics Laboratories, Inc.
6.6. Predictive Oncology Inc.
6.7. QIAGEN GmbH
6.8. RefleXion Medical, Inc.
6.9. Siemens Healthineers
6.10. STEMCELL Technologies Inc.
6.11. Thermo Fisher Scientific Inc.
6.12. Varian Medical Systems, Inc.
1. GLOBAL TUMOR TRACKING SYSTEMS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
2. GLOBAL TUMOR TRACKING SYSTEMS FOR PROSTATE CANCER MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
3. GLOBAL TUMOR TRACKING SYSTEMS FOR GASTRIC CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
4. GLOBAL TUMOR TRACKING SYSTEMS FOR LUNG CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
5. GLOBAL TUMOR TRACKING SYSTEMS FOR BREAST CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
6. GLOBAL TUMOR TRACKING SYSTEMS FOR OTHER APPLICATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
7. GLOBAL TUMOR TRACKING SYSTEMS MARKET RESEARCH AND ANALYSIS BY END USER, 2022-2030 ($ MILLION)
8. GLOBAL TUMOR TRACKING SYSTEMS IN HOSPITALS MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
9. GLOBAL TUMOR TRACKING SYSTEMS IN RADIOTHERAPY CENTERS MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
10. GLOBAL TUMOR TRACKING SYSTEMS IN CANCER RESEARCH INSTITUTES MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
11. GLOBAL TUMOR TRACKING SYSTEMS FOR OTHER END USERS MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
12. GLOBAL TUMOR TRACKING SYSTEMS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
13. NORTH AMERICAN TUMOR TRACKING SYSTEMS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
14. NORTH AMERICAN TUMOR TRACKING SYSTEMS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
15. NORTH AMERICAN TUMOR TRACKING SYSTEMS MARKET RESEARCH AND ANALYSIS BY END USER, 2022-2030 ($ MILLION)
16. EUROPEAN TUMOR TRACKING SYSTEMS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
17. EUROPEAN TUMOR TRACKING SYSTEMS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
18. EUROPEAN TUMOR TRACKING SYSTEMS MARKET RESEARCH AND ANALYSIS BY END USER, 2022-2030 ($ MILLION)
19. ASIA- PACIFIC TUMOR TRACKING SYSTEMS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
20. ASIA- PACIFIC TUMOR TRACKING SYSTEMS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
21. ASIA- PACIFIC TUMOR TRACKING SYSTEMS MARKET RESEARCH AND ANALYSIS BY END USER, 2022-2030 ($ MILLION)
22. REST OF THE WORLD TUMOR TRACKING SYSTEMS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
23. REST OF THE WORLD TUMOR TRACKING SYSTEMS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
24. REST OF THE WORLD TUMOR TRACKING SYSTEMS MARKET RESEARCH AND ANALYSIS BY END USER, 2022-2030 ($ MILLION)
1. GLOBAL TUMOR TRACKING SYSTEMS MARKET SHARE BY APPLICATION, 2022 VS 2030 (%)
2. GLOBAL TUMOR TRACKING SYSTEMS FOR PROSTATE CANCER MARKET SHARE BY REGION, 2022 VS 2030 (%)
3. GLOBAL TUMOR TRACKING SYSTEMS FOR GASTRIC CANCER MARKET SHARE BY REGION, 2022 VS 2030 (%)
4. GLOBAL TUMOR TRACKING SYSTEMS FOR LUNG CANCER MARKET SHARE BY REGION, 2022 VS 2030 (%)
5. GLOBAL TUMOR TRACKING SYSTEMS FOR BREAST CANCER MARKET SHARE BY REGION, 2022 VS 2030 (%)
6. GLOBAL TUMOR TRACKING SYSTEMS FOR OTHER APPLICATIONS MARKET SHARE BY REGION, 2022 VS 2030 (%)
7. GLOBAL TUMOR TRACKING SYSTEMS MARKET SHARE BY END USER, 2022 VS 2030 (%)
8. GLOBAL TUMOR TRACKING SYSTEMS IN HOSPITALS MARKET SHARE BY REGION, 2022 VS 2030 (%)
9. GLOBAL TUMOR TRACKING SYSTEMS IN RADIOTHERAPY CENTERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
10. GLOBAL TUMOR TRACKING SYSTEMS IN CANCER RESEARCH INSTITUTES MARKET SHARE BY REGION, 2022 VS 2030 (%)
11. GLOBAL TUMOR TRACKING SYSTEMS IN OTHER END USERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
12. GLOBAL TUMOR TRACKING SYSTEMS MARKET SHARE BY REGION, 2022 VS 2030 (%)
13. US TUMOR TRACKING SYSTEMS MARKET SIZE, 2022-2030 ($ MILLION)
14. CANADA TUMOR TRACKING SYSTEMS MARKET SIZE, 2022-2030 ($ MILLION)
15. UK TUMOR TRACKING SYSTEMS MARKET SIZE, 2022-2030 ($ MILLION)
16. FRANCE TUMOR TRACKING SYSTEMS MARKET SIZE, 2022-2030 ($ MILLION)
17. GERMANY TUMOR TRACKING SYSTEMS MARKET SIZE, 2022-2030 ($ MILLION)
18. ITALY TUMOR TRACKING SYSTEMS MARKET SIZE, 2022-2030 ($ MILLION)
19. SPAIN TUMOR TRACKING SYSTEMS MARKET SIZE, 2022-2030 ($ MILLION)
20. REST OF EUROPE TUMOR TRACKING SYSTEMS MARKET SIZE, 2022-2030 ($ MILLION)
21. INDIA TUMOR TRACKING SYSTEMS MARKET SIZE, 2022-2030 ($ MILLION)
22. CHINA TUMOR TRACKING SYSTEMS MARKET SIZE, 2022-2030 ($ MILLION)
23. JAPAN TUMOR TRACKING SYSTEMS MARKET SIZE, 2022-2030 ($ MILLION)
24. SOUTH KOREA TUMOR TRACKING SYSTEMS MARKET SIZE, 2022-2030 ($ MILLION)
25. REST OF ASIA-PACIFIC TUMOR TRACKING SYSTEMS MARKET SIZE, 2022-2030 ($ MILLION)
26. REST OF THE WORLD TUMOR TRACKING SYSTEMS MARKET SIZE, 2022-2030 ($ MILLION)
